Scholarlink

<p>Developmental and reproductive toxicity (DART) assessment is essential for product safety evaluation but relies heavily on vertebrate models that are costly, time consuming, and resource intensive. Although <i>Caenorhabditis elegans</i> has emerged as a promising new approach methodology (NAM) for rapid, cost-effective, whole-organism toxicology, broader adoption has been limited by the lack of high-resolution, rapid imaging approaches, limited endpoints, and insufficient evidence supporting assay robustness. To overcome these limitations, we developed vivoDART, a multiparametric imaging-based DART assay designed to be accurate, efficient, robust, and sensitive. Building on our machine learning-accelerated developmental toxicity platform, vivoDART uses microfluidic-assisted, high-resolution brightfield imaging to quantify six developmental and reproductive endpoints for comprehensive DART analysis. Developmental endpoints are derived from automated body-dimension analysis, whereas reproductive endpoints are obtained by quantifying total in utero embryo number and classifying embryos as early- or late-stage relative to the twofold stage. The assay directly assesses sublethal DART phenotypes while minimizing reliance on non-specific apical endpoints such as lethality. vivoDART demonstrated high repeatability, with mean coefficients of variation of 1–5% for developmental endpoints and 6–17% for reproductive endpoints, supporting high statistical power. Assay validation performed using DMSO, methylmercury, and propiconazole involved phenotyping ~ 400,000 embryos across ~ 9,200 worms. Densely sampled concentration–response curves enabled EC<sub>x</sub> prediction with narrow confidence intervals and captured subtle to strong effects across a broad dynamic range of 1.0–237&#xa0;µM. Notably, late-stage embryo number was the most sensitive endpoint among the chemicals tested, preceding changes in total embryo number, body size, or viability. These findings indicate that the observed responses reflected DART-specific effects rather than non-specific lethality. These results establish vivoDART as a sensitive, repeatable, and scalable whole-organism platform for rapid, cost-effective chemical prioritization and comparative hazard assessment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A robust, high-content NAM for repeatable and predictive developmental and reproductive toxicity assessment in C. elegans

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月10日

查看全文
  • Sudip Mondal,
  • Adam Laing,
  • Amber Shen,
  • Evan Hegarty,
  • Abhishri Medewar,
  • Sebastian Gomez,
  • Gina Carrion,
  • Julia Brown,
  • Piper Hunt,
  • Adela Ben-Yakar

摘要

Developmental and reproductive toxicity (DART) assessment is essential for product safety evaluation but relies heavily on vertebrate models that are costly, time consuming, and resource intensive. Although Caenorhabditis elegans has emerged as a promising new approach methodology (NAM) for rapid, cost-effective, whole-organism toxicology, broader adoption has been limited by the lack of high-resolution, rapid imaging approaches, limited endpoints, and insufficient evidence supporting assay robustness. To overcome these limitations, we developed vivoDART, a multiparametric imaging-based DART assay designed to be accurate, efficient, robust, and sensitive. Building on our machine learning-accelerated developmental toxicity platform, vivoDART uses microfluidic-assisted, high-resolution brightfield imaging to quantify six developmental and reproductive endpoints for comprehensive DART analysis. Developmental endpoints are derived from automated body-dimension analysis, whereas reproductive endpoints are obtained by quantifying total in utero embryo number and classifying embryos as early- or late-stage relative to the twofold stage. The assay directly assesses sublethal DART phenotypes while minimizing reliance on non-specific apical endpoints such as lethality. vivoDART demonstrated high repeatability, with mean coefficients of variation of 1–5% for developmental endpoints and 6–17% for reproductive endpoints, supporting high statistical power. Assay validation performed using DMSO, methylmercury, and propiconazole involved phenotyping ~ 400,000 embryos across ~ 9,200 worms. Densely sampled concentration–response curves enabled ECx prediction with narrow confidence intervals and captured subtle to strong effects across a broad dynamic range of 1.0–237 µM. Notably, late-stage embryo number was the most sensitive endpoint among the chemicals tested, preceding changes in total embryo number, body size, or viability. These findings indicate that the observed responses reflected DART-specific effects rather than non-specific lethality. These results establish vivoDART as a sensitive, repeatable, and scalable whole-organism platform for rapid, cost-effective chemical prioritization and comparative hazard assessment.